Richard Sloan, MD
Nephrology · Evansville, INNPI 1467452821
Payments from drug & device makers
Across 108 payments — averaging $18.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$486
- Calliditas Therapeutics US Inc.$210
- Travere Therapeutics, Inc.$207
- Otsuka America Pharmaceutical, Inc.$206
- Amgen$200
- Akebia Therapeutics Inc$194
- plus $547 from 12 others
What the payments were for
- Food & beverage$2,050100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 27 | $486 |
| Calliditas Therapeutics US Inc. | 9 | $210 |
| Travere Therapeutics, Inc. | 8 | $207 |
| Otsuka America Pharmaceutical, Inc. | 11 | $206 |
| Amgen | 11 | $200 |
| Akebia Therapeutics Inc | 12 | $194 |
| Bayer | 11 | $158 |
| Ardelyx, Inc. | 3 | $72 |
| Mallinckrodt Hospital Products Inc. | 3 | $62 |
| Novartis | 3 | $58 |
| GSK | 3 | $55 |
| Aurinia Pharma U.S., Inc. | 1 | $26 |
| Ultragenyx Pharmaceutical Inc. | 1 | $25 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Vifor Pharma, Inc. | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $17 |
| La Jolla Pharmaceutical Company | 1 | $17 |
How this compares
$2,050 in reported general payments places this provider in the 60th percentile of 238 nephrology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Calcium Acetate | 37 | $871 |
| Furosemide | 50 | $321 |
| Potassium Chloride | 11 | $255 |
| Losartan Potassium | 17 | $203 |
| Amlodipine Besylate | 19 | $186 |
| Allopurinol | 13 | $86 |
| Carvedilol | 18 | $81 |
| Alprazolam | 18 | $16 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Evansville
- Narothama Reddy AeddulaEvansville$125K
- James EvansonEvansville$21K
- Andrew OshaughnessyFort Wayne$1.2M
- Rajiv AgarwalIndianapolis$1.2M
- Garima GuptaFort Wayne$666K
- Jay WishIndianapolis$502K
- Bruce MolitorisIndianapolis$471K
- Kenneth ChoiMerrillville$392K
- Arjun SinhaIndianapolis$315K
- Sharon MoeIndianapolis$298K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.